Gene · 4985
Papers1,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimizing a culture-based approach to detect intestinal carriage of carbapenem-resistant Pseudomonas aeruginosa in humans. | J Glob Antimicrob Resist | 2026 | 42697436 | PubTator, text mining | PubMed |
| Effect of dissolved versus total zinc levels on bacterial zinc-dependent meropenem co-resistance in River Tyne sediments. | Environ Pollut | 2026 | 42668131 | PubTator, text mining | PubMed |
| The Pharmacogenomics of Opioid Response in Cancer Pain: From Receptor Polymorphisms to Tumour-Mediated Interference-A Narrative-Critical Review. | Int J Mol Sci | 2026 | 42589662 | PubTator, text mining | PubMed |
| Role of genetic polymorphisms on opioid safety and efficacy in cancer pain: A systematic review and meta-analysis. | Eur J Pharmacol | 2026 | 42492880 | PubTator, text mining | PubMed |
| OPRD1 rs4654327 and Outcomes of Extended-Release Naltrexone in Alcohol Use Disorder: An Exploratory Prospective Pharmacogenetic Study. | Psychopharmacology (Berl) | 2026 | 42373990 | PubTator, text mining | PubMed |
| Characterization of antimicrobial resistance and virulence traits of clinical Pseudomonas mosselii isolates with reduced meropenem susceptibility and preserved imipenem susceptibility. | Microbiol Spectr | 2026 | 42206854 | PubTator, text mining | PubMed |
| The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorder. | Sci Rep | 2026 | 42135448 | PubTator, text mining | PubMed |
| [OPRD1 gene polymorphism (rs4654327) as a potential predictor of the effectiveness of long-acting naltrexone in patients with alcohol addiction]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2026 | 42133415 | PubTator, text mining | PubMed |
| Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates obtained from patients treated in a paediatric hospital in Mexico. | Sci Rep | 2026 | 42014478 | PubTator, text mining | PubMed |
| Differences in Experimental Pain Sensitivity Between Non-African and African American Healthy Individuals and Patients with Painful Chronic Pancreatitis. | J Pain Res | 2026 | 41788416 | PubTator, text mining | PubMed |
Molecular epidemiological association between antimicrobial resistance characteristics and type III secretion system in carbapenem-resistant Pseudomonas aeruginosa from lower respiratory tract infections. | Front Cell Infect Microbiol | 2026 | 41782943 | PubTator, text mining | PubMed |
| Particularities in Surgical Results Following Obstetrical and Gynecological Surgery Using Pharmacological, Anesthesiological and Genetic Markers. | J Pers Med | 2026 | 41745367 | PubTator, text mining | PubMed |
| A Machine Learning-Guided Approach for Identifying Potential HCAR1 Antagonists in Lactate-Driven Cancers. | ACS Omega | 2026 | 41726659 | PubTator, text mining | PubMed |
| A key component fumarine of Sijunzi decoction induces necroptosis in clear cell renal cell carcinoma potentially via targeting SLC6A3, OPRD1 and KDR. | Biochem Biophys Res Commun | 2026 | 41722251 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomisation identifies causal links between blood proteins and myopia. | J Glob Health | 2026 | 41718003 | PubTator, text mining | PubMed |
| Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae. | Infect Drug Resist | 2026 | 41716896 | PubTator, text mining | PubMed |
| Antibiotic resistance of Pseudomonas aeruginosa strains-intracellular metabolomics analysis. | J Antimicrob Chemother | 2026 | 41549664 | PubTator, text mining | PubMed |
| PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse. | Curr Neuropharmacol | 2026 | 40993956 | PubTator, text mining | PubMed |
| Identification of variants from gene expression data of opioid-addicted patients. | J Appl Genet | 2026 | 40627269 | PubTator, text mining | PubMed |
| Across preclinical and clinical platforms, approved and investigational psychiatric drugs share pathways and associate with similar molecular functions. | Front Drug Discov (Lausanne) | 2025 | 42239657 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4985/papers